This article is part of the supplement: Basic science, rationale, background and future of denosumab: a RANK ligand inhibitor
Multiple myeloma/hypercalcemia
Arthritis Research & Therapy 2007, 9(Suppl 1):S4 doi:10.1186/ar2168
No comments have yet been made on this article.
